TELMISARTAN Side Effects

7007421-1 | Delirium, Disorientation, Speech Disorder, Therapeutic Agent Toxicity
on Sep 17, 2010 Female patient from , 67 years of age, was diagnosed with hypertension, ischaemic heart disease prophylaxis, depression (What is depression?), tremor, hyperuricaemia, hypothyroidism and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, disorientation, speech disorder, therapeutic agent toxicity. Telmisartan dosage: 92.5 Mg. During the same period patient was treated with ACETYLSALICYLIC ACID (100 Mg) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), LITHIUM APOGEPHA (100 Mg Bid) (View Lithium Apogepha Review and Lithium Apogepha Label ), FURANTHRIL (40 Mg) (View Furanthril Review and Furanthril Label ), TRIMIPRAMINE MALEATE (100 Mg) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), AKINETON (2 Mg) (View Akineton Review and Akineton Label ), ALLOPURINOL (100 Mg) (View Allopurinol Review and Allopurinol Label ), BERLTHYROX (150 Mg) (View Berlthyrox Review and Berlthyrox Label ), BISOPROLOL (2.5 Mg Bid) (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6917791-8 | Accidental Overdose
Patient was taking Telmisartan (View Usage). Patient had the following side effects: accidental overdose on Aug 04, 2010 from Additional patient health information: Male patient , child 2 years of age, . Telmisartan dosage: . Patient was hospitalized.

6835358-7 | Bacterial Infection, Face Oedema, Facial Pain, Herpes Zoster, Rash
Adverse event was reported on Jul 06, 2010 by a Male patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with eye disorder and. Location: , 79 years of age, After Telmisartan was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), face oedema, facial pain, herpes zoster, rash (What is rash?). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FAMCICLOVIR (View Famciclovir Review and Famciclovir Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6578558-6 | Erythema Multiforme, Pyrexia
on Feb 03, 2010 Female patient from , 80 years of age, was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, pyrexia. Telmisartan dosage: . During the same period patient was treated with CEFDINIR (View Cefdinir Review and Cefdinir Label ).


6396822-0 | Aphasia, Confusional State, Hyponatraemia, Lethargy
on Oct 05, 2009 Female patient from , 76 years of age, weighting 124.1 lb, was diagnosed with hypertension, depression (What is depression?) and was treated with Telmisartan (View Usage). Patient had the following side effects: aphasia (What is aphasia?), confusional state, hyponatraemia, lethargy. Telmisartan dosage: . During the same period patient was treated with MIRTAZAPINE (30 Mg) (View Mirtazapine Review and Mirtazapine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6326001-4 | Nephropathy Toxic, Renal Failure Acute
Patient was taking Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: nephropathy toxic, renal failure acute on Aug 10, 2009 from Additional patient health information: Female patient , 66 years of age, was diagnosed with hypertension, percutaneous coronary intervention, acute myocardial infarction and. Telmisartan dosage: . During the same period patient was treated with IOPAMIDOL (View Iopamidol Review and Iopamidol Label ), OXYGEN (View Oxygen Review and Oxygen Label ), HEPARIN (View Heparin Review and Heparin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6318435-9 | Nephropathy Toxic, Renal Failure Acute
Adverse event was reported on Aug 10, 2009 by a Female patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, percutaneous coronary intervention, acute myocardial infarction and. Location: , 66 years of age, Patient experienced the following unwanted or unexpected effects: nephropathy toxic, renal failure acute. During the same period patient was treated with IOPAMIDOL (View Iopamidol Review and Iopamidol Label ), OXYGEN (View Oxygen Review and Oxygen Label ), HEPARIN (View Heparin Review and Heparin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6307016-9 | Anaemia, Blood Creatinine Increased, Disease Progression, Dyspnoea, Hyperglycaemia, Pneumonia, Renal Failure
on Aug 04, 2009 Male patient from , weighting 218.0 lb, was diagnosed with cardiovascular disorder and was treated with Telmisartan (View Usage). Patient had the following side effects: anaemia, blood creatinine increased, disease progression, dyspnoea, hyperglycaemia, pneumonia (What is pneumonia?), renal failure. Telmisartan dosage: . Patient was hospitalized.

6292036-3 | Arteriosclerosis, Hypoglycaemia
on Jun 09, 2009 Male patient from , 54 years of age, weighting 156.5 lb, was diagnosed with diabetic nephropathy and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: arteriosclerosis, hypoglycaemia. Telmisartan dosage: 80mg. During the same period patient was treated with DIURETIC (View Diuretic Review and Diuretic Label ), URIC ACID BIOSYNTHESIS INHIBITOR (View Uric Acid Biosynthesis Inhibitor Review and Uric Acid Biosynthesis Inhibitor Label ), SARPOGRELATE (View Sarpogrelate Review and Sarpogrelate Label ).

6231851-9 | Abdominal Pain, Diarrhoea, Leukocytoclastic Vasculitis, Purpura, Pyrexia, Renal Failure, Thrombotic Thrombocytopenic Purpura, Toxic Skin Eruption
Patient was taking Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, leukocytoclastic vasculitis, purpura, pyrexia, renal failure, thrombotic thrombocytopenic purpura, toxic skin eruption on Jun 09, 2009 from Additional patient health information: Male patient , 68 years of age, . Telmisartan dosage: . During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), TICLOPIDINE (View Ticlopidine Review and Ticlopidine Label ). Patient was hospitalized.

6230289-8 | Abdominal Pain Upper, Chest Discomfort, Dizziness, Dyspnoea, Hyperkalaemia, Hypotension, Nodal Rhythm, Sick Sinus Syndrome, Tumour Lysis Syndrome
Adverse event was reported on Apr 06, 2009 by a Female patient taking Telmisartan (View Usage) (Dosage: 40mg) was diagnosed with hypertension, ascites, hepatic neoplasm malignant recurrent and. Location: , 81 years of age, Patient had the following side effects: abdominal pain upper, chest discomfort, dizziness (What is dizziness?), dyspnoea, hyperkalaemia, hypotension, nodal rhythm, sick sinus syndrome, tumour lysis syndrome. During the same period patient was treated with LERCANIDIPINE (10mg) (View Lercanidipine Review and Lercanidipine Label ), INDAPAMIDE (1.5mg) (View Indapamide Review and Indapamide Label ), SPIRONOLACTONE (50mg) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (20mg) (View Furosemide Review and Furosemide Label ), THALIDOMIDE (50mg) (View Thalidomide Review and Thalidomide Label ). Patient was hospitalized.

6230280-1 | Hypertensive Crisis, Hyponatraemia
on May 29, 2009 Female patient from , 70 years of age, was diagnosed with hypertension and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: hypertensive crisis, hyponatraemia. Telmisartan dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TRIMIPRAMINE MALEATE (View Trimipramine Maleate Review and Trimipramine Maleate Label ). Patient was hospitalized.

6230279-5 | Arteriosclerosis, Hypoglycaemia
on Jun 09, 2009 Male patient from , 54 years of age, weighting 156.5 lb, was diagnosed with diabetic nephropathy and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, hypoglycaemia. Telmisartan dosage: 80mg. During the same period patient was treated with DIURETIC (View Diuretic Review and Diuretic Label ), URIC ACID BIOSYNTHESIS INHIBITOR (View Uric Acid Biosynthesis Inhibitor Review and Uric Acid Biosynthesis Inhibitor Label ), SARPOGRELATE (View Sarpogrelate Review and Sarpogrelate Label ).

6185695-7 | Delirium, Disorientation, Speech Disorder
Patient was taking Telmisartan (View Usage). Patient had the following side effects: delirium, disorientation, speech disorder on May 04, 2009 from Additional patient health information: Female patient , 67 years of age, was diagnosed with hypertension, ischaemic heart disease prophylaxis, depression (What is depression?), tremor, hyperuricaemia, hypothyroidism and. Telmisartan dosage: 92.5mg. During the same period patient was treated with ASPIRIN (100mg) (View Aspirin Review and Aspirin Label ), LITHIUM CARBONATE (2anz) (View Lithium Carbonate Review and Lithium Carbonate Label ), FURANTHRIL (40mg) (View Furanthril Review and Furanthril Label ), TRIMIPRAMINE MALEATE (100mg) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), AKINETON (2mg) (View Akineton Review and Akineton Label ), ALLOPURINOL (100mg) (View Allopurinol Review and Allopurinol Label ), BERLTHYROX (150mg) (View Berlthyrox Review and Berlthyrox Label ), BISOPROLOL FUMARATE (2anz) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6183950-8 | Delirium
Adverse event was reported on May 04, 2009 by a Female patient taking Telmisartan (View Usage) (Dosage: 92.5mg) was diagnosed with hypertension, ischaemic heart disease prophylaxis, depression (What is depression?), tremor, hyperuricaemia, hypothyroidism and. Location: , 67 years of age, After Telmisartan was administered, patient had the following side effects: delirium. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (100mg) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), LITHIUM CARBONATE (2anz) (View Lithium Carbonate Review and Lithium Carbonate Label ), FURANTHRIL (40mg) (View Furanthril Review and Furanthril Label ), TRIMIPRAMINE MALEATE (100mg) (View Trimipramine Maleate Review and Trimipramine Maleate Label ), AKINETON (2mg) (View Akineton Review and Akineton Label ), ALLOPURINOL (100mg) (View Allopurinol Review and Allopurinol Label ), BERLTHYROX (150mg) (View Berlthyrox Review and Berlthyrox Label ), BISOPROLOL (2anz) (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6161457-1 | Hepatic Failure, Renal Failure, Rhabdomyolysis
on Apr 16, 2009 Female patient from , 66 years of age, was diagnosed with hypertension, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?) and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure, renal failure, rhabdomyolysis. Telmisartan dosage: 80mg. During the same period patient was treated with ROSUVASTATIN CALCIUM (10mg) (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), WARFARIN SODIUM (2.5mg) (View Warfarin Sodium Review and Warfarin Sodium Label ), RANITIDINE (150mg) (View Ranitidine Review and Ranitidine Label ), FUROSEMIDE (25mg) (View Furosemide Review and Furosemide Label ), CARVEDILOL (12.5mg) (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6155373-9 | Abdominal Pain Upper, Chest Discomfort, Dizziness, Dyspnoea, Hyperkalaemia, Hypotension, Nodal Rhythm, Sick Sinus Syndrome, Tumour Lysis Syndrome
on Apr 06, 2009 Female patient from , 81 years of age, was diagnosed with hypertension, ascites, hepatic neoplasm malignant recurrent and was treated with Telmisartan (View Usage). Patient had the following side effects: abdominal pain upper, chest discomfort, dizziness (What is dizziness?), dyspnoea, hyperkalaemia, hypotension, nodal rhythm, sick sinus syndrome, tumour lysis syndrome. Telmisartan dosage: 40mg. During the same period patient was treated with LERCANIDIPINE (10mg) (View Lercanidipine Review and Lercanidipine Label ), INDAPAMIDE (1.5mg) (View Indapamide Review and Indapamide Label ), SPIRONOLACTONE (50mg) (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (20mg) (View Furosemide Review and Furosemide Label ), THALIDOMIDE (50mg) (View Thalidomide Review and Thalidomide Label ). Patient was hospitalized.

6132467-5 | Colitis
Patient was taking Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: colitis on Mar 20, 2009 from Additional patient health information: Male patient , 57 years of age, . Telmisartan dosage: .

6132465-1 | Colitis
Adverse event was reported on Mar 20, 2009 by a Male patient taking Telmisartan (View Usage) (Dosage: ) . Location: , 55 years of age, Patient experienced the following unwanted or unexpected effects: colitis.

6132462-6 | Colitis
on Mar 20, 2009 Male patient from , 60 years of age, was treated with Telmisartan (View Usage). Patient had the following side effects: colitis. Telmisartan dosage: .

6127057-4 | Colitis
on Mar 11, 2009 Male patient from , 57 years of age, was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: colitis. Telmisartan dosage: .

6127056-2 | Colitis
Patient was taking Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: colitis on Mar 11, 2009 from Additional patient health information: Male patient , 55 years of age, . Telmisartan dosage: .

6127053-7 | Colitis
Adverse event was reported on Mar 11, 2009 by a Male patient taking Telmisartan (View Usage) (Dosage: ) . Location: , 60 years of age, Patient had the following side effects: colitis.

5939348-8 | Pemphigus
on Oct 30, 2008 Female patient from , 76 years of age, was diagnosed with hypertension, diabetes mellitus, hyperlipidaemia, pemphigus (What is pemphigus?), cardiovascular disorder and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: pemphigus (What is pemphigus?). Telmisartan dosage: . During the same period patient was treated with ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TOPICAL STEROIDS (View Topical Steroids Review and Topical Steroids Label ), AZATHIOPRINE (100mg) (View Azathioprine Review and Azathioprine Label ), ANTIHISTAMINE (View Antihistamine Review and Antihistamine Label ).

5900560-5 | Dermatitis, Somnolence, Syncope, Tinnitus, Vertigo Positional
on Sep 18, 2008 Male patient from , 70 years of age, was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis, somnolence, syncope, tinnitus (What is tinnitus?), vertigo positional. Telmisartan dosage: 80mg.

5878376-8 | Pemphigus
Patient was taking Telmisartan (View Usage). Patient had the following side effects: pemphigus (What is pemphigus?) on Sep 11, 2008 from Additional patient health information: Female patient , 76 years of age, was diagnosed with hypertension, diabetes mellitus, hyperlipidaemia, pemphigus (What is pemphigus?), cardiovascular disorder and. Telmisartan dosage: . During the same period patient was treated with ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), TOPICAL STEROIDS (View Topical Steroids Review and Topical Steroids Label ), AZATHIOPRINE (100mg) (View Azathioprine Review and Azathioprine Label ), ANTIHISTAMINE (View Antihistamine Review and Antihistamine Label ).

5877156-7 | Pemphigus
Adverse event was reported on Sep 09, 2008 by a Female patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, diabetes mellitus, hyperlipidaemia, pemphigus (What is pemphigus?), cardiovascular disorder and. Location: , 76 years of age, After Telmisartan was administered, patient had the following side effects: pemphigus (What is pemphigus?). During the same period patient was treated with ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), TOPICAL STEROIDS (View Topical Steroids Review and Topical Steroids Label ), AZATHIOPRINE (100mg) (View Azathioprine Review and Azathioprine Label ), ANTIHISTAMINE (View Antihistamine Review and Antihistamine Label ).

5871820-1 | Pemphigus
on Aug 20, 2008 Female patient from , 76 years of age, was diagnosed with hypertension, diabetes mellitus, hyperlipidaemia, pemphigus (What is pemphigus?), cardiovascular disorder and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigus (What is pemphigus?). Telmisartan dosage: . During the same period patient was treated with PREDNISOLONE (Rt: 10-30 Mg Qd) (View Prednisolone Review and Prednisolone Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), TOPICAL STEROIDS (View Topical Steroids Review and Topical Steroids Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), ANTIHISTAMINE (View Antihistamine Review and Antihistamine Label ).

5848761-9 | Angioedema, Blood Glucose, Hepatic Steatosis, Lipids Increased, Urinary Tract Infection
on Aug 07, 2008 Male patient from , 42 years of age, was diagnosed with hypertension and was treated with Telmisartan (View Usage). Patient had the following side effects: angioedema, blood glucose, hepatic steatosis, lipids increased, urinary tract infection (What is urinary tract infection?). Telmisartan dosage: . During the same period patient was treated with DULOXETINE (View Duloxetine Review and Duloxetine Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

5748188-4 | Dizziness, Nausea, Visual Acuity Reduced
Patient was taking Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?), visual acuity reduced on May 14, 2008 from Additional patient health information: Female patient , 50 years of age, was diagnosed with hypertension and. Telmisartan dosage: .

5748140-9 | Blood Creatinine Increased, Blood Pressure Systolic Increased, Dizziness, Hypertension, Pneumonia, Urinary Tract Infection
Adverse event was reported on May 19, 2008 by a Male patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with renovascular hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?) and. Location: , 66 years of age, weighting 127.0 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood pressure systolic increased, dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GUANABENZ (View Guanabenz Review and Guanabenz Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ).

5742406-4 | Blood Creatinine Increased, Blood Pressure Systolic Increased, Dizziness, Hypertension, Pneumonia, Urinary Tract Infection
on May 15, 2008 Male patient from GERMANY , 66 years of age, weighting 127.9 lb, was diagnosed with renovascular hypertension, pneumonia (What is pneumonia?) and was treated with Telmisartan (View Usage). Patient had the following side effects: blood creatinine increased, blood pressure systolic increased, dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Telmisartan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GUANABENZ (View Guanabenz Review and Guanabenz Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5580846-7 | Abortion Induced, Weight Decreased
on Jan 02, 2008 Female patient from , 32 years of age, weighting 222.7 lb, was diagnosed with hypertension and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: abortion induced, weight decreased. Telmisartan dosage: .

5547665-9 | Anuria, Coma, Condition Aggravated, Hypotension, Renal Failure Acute, Respiratory Failure
Patient was taking Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, coma, condition aggravated, hypotension, renal failure acute, respiratory failure on Dec 06, 2007 from Additional patient health information: Male patient , 60 years of age, weighting 163.1 lb, was diagnosed with hypertension, muscle spasticity, diabetes mellitus, pneumonia (What is pneumonia?) and. Telmisartan dosage: . During the same period patient was treated with GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), INSULIN (View Insulin Review and Insulin Label ), AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ). Patient was hospitalized.

5481818-3 | Pyrexia, Rash, Stevens-johnson Syndrome, Swelling Face
Adverse event was reported on Oct 09, 2007 by a Female patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, hyperuricaemia and. Location: , 67 years of age, Patient had the following side effects: pyrexia, rash (What is rash?), stevens-johnson syndrome, swelling face. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BENIDIPINE (View Benidipine Review and Benidipine Label ). Patient was hospitalized.

5408121-1 | Blood Creatinine Increased, Blood Pressure Systolic Increased, Dizziness, Hypertension, Pneumonia, Urinary Tract Infection
on Jul 26, 2007 Male patient from GERMANY , 66 years of age, weighting 127.9 lb, was diagnosed with renovascular hypertension, pneumonia (What is pneumonia?) and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: blood creatinine increased, blood pressure systolic increased, dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Telmisartan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GUANABENZ (View Guanabenz Review and Guanabenz Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5405394-6 | Blood Creatinine Increased, Blood Pressure Systolic Increased, Dizziness, Hypertension, Pneumonia, Urinary Tract Infection
on Jul 26, 2007 Male patient from , 66 years of age, weighting 127.0 lb, was diagnosed with renovascular hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?) and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood pressure systolic increased, dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?). Telmisartan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GUANABENZ (View Guanabenz Review and Guanabenz Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ).

5400957-6 | Blood Creatinine Increased, Blood Pressure Systolic Increased, Dizziness, Hypertension, Pneumonia, Urinary Tract Infection
Patient was taking Telmisartan (View Usage). Patient had the following side effects: blood creatinine increased, blood pressure systolic increased, dizziness (What is dizziness?), hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?) on Dec 13, 2005 from Additional patient health information: Male patient , 66 years of age, weighting 127.0 lb, was diagnosed with renovascular hypertension, pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?) and. Telmisartan dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), GUANABENZ (View Guanabenz Review and Guanabenz Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ANTIBIOTIC (View Antibiotic Review and Antibiotic Label ).

5388652-3 | Proteinuria
Adverse event was reported on Jul 06, 2007 by a Male patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, proteinuria, metastatic renal cell carcinoma and. Location: , 59 years of age, After Telmisartan was administered, patient had the following side effects: proteinuria. During the same period patient was treated with BEVACIZUMAB (10 Mg/kg Over 1.5 H) (View Bevacizumab Review and Bevacizumab Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), INTERFERON ALFA 2B (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

5332587-9 | Skin Lesion, Vasculitis, Vulval Disorder, Vulvitis
on Apr 23, 2007 Female patient from , 77 years of age, was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: skin lesion, vasculitis (What is vasculitis?), vulval disorder, vulvitis. Telmisartan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5318337-0 | Skin Lesion, Vasculitis, Vulval Disorder, Vulvitis
on Apr 23, 2007 Female patient from , 77 years of age, was treated with Telmisartan (View Usage). Patient had the following side effects: skin lesion, vasculitis (What is vasculitis?), vulval disorder, vulvitis. Telmisartan dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

5273152-1 | Hypokalaemia
Patient was taking Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: hypokalaemia on Mar 09, 2007 from Additional patient health information: Female patient , 65 years of age, was diagnosed with hypertension and. Telmisartan dosage: .

5265386-7 | Confusional State
Adverse event was reported on Mar 08, 2007 by a Female patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, prophylaxis of nausea and vomiting, colorectal cancer metastatic and. Location: UNITED STATES , weighting 128.3 lb, Patient experienced the following unwanted or unexpected effects: confusional state. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5216250-0 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Diarrhoea, Gamma-glutamyltransferase Increased, Nausea, Weight Increased
on Jan 09, 2007 Male patient from , 77 years of age, was diagnosed with essential hypertension and was treated with Telmisartan (View Usage). Patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, gamma-glutamyltransferase increased, nausea (What is nausea?), weight increased. Telmisartan dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5206298-4 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Diarrhoea, Gamma-glutamyltransferase Increased, Nausea, Weight Increased
on Jan 09, 2007 Male patient from , 77 years of age, was diagnosed with essential hypertension and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, gamma-glutamyltransferase increased, nausea (What is nausea?), weight increased. Telmisartan dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5133164-5 | Anaemia, Neutropenia
Patient was taking Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, neutropenia on Oct 05, 2006 from Additional patient health information: Female patient , 74 years of age, was diagnosed with hypertension, right ventricular failure and. Telmisartan dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5127938-4 | Anaemia, Neutropenia
Adverse event was reported on Oct 05, 2006 by a Female patient taking Telmisartan (View Usage) (Dosage: ) was diagnosed with hypertension, right ventricular failure and. Location: , 74 years of age, Patient had the following side effects: anaemia, neutropenia. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5116302-X | Arterial Occlusive Disease
on Sep 19, 2006 Male patient from , 68 years of age, was diagnosed with hypertension and was treated with Telmisartan (View Usage). After Telmisartan was administered, patient had the following side effects: arterial occlusive disease. Telmisartan dosage: . During the same period patient was treated with GLIQUIDONE (View Gliquidone Review and Gliquidone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

5089117-9 | Erectile Dysfunction
on Aug 10, 2006 Male patient from , 44 years of age, was diagnosed with essential hypertension, lipid metabolism disorder and was treated with Telmisartan (View Usage). Patient experienced the following unwanted or unexpected effects: erectile dysfunction (What is erectile dysfunction?). Telmisartan dosage: . During the same period patient was treated with FLUVASTATIN SODIUM CAPSULE (View Fluvastatin Sodium Capsule Review and Fluvastatin Sodium Capsule Label ), REPORTED IN NARRATIVE (View Reported In Narrative Review and Reported In Narrative Label ).

4929472-0 | Lymphocyte Stimulation Test Positive, Pyrexia, Rash, Stevens-johnson Syndrome, Swelling Face
Patient was taking Telmisartan (View Usage). Patient had the following side effects: lymphocyte stimulation test positive, pyrexia, rash (What is rash?), stevens-johnson syndrome, swelling face on Nov 14, 2005 from Additional patient health information: Female patient , 67 years of age, was diagnosed with hypertension, hyperuricaemia and. Telmisartan dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BENIDIPINE (View Benidipine Review and Benidipine Label ). Patient was hospitalized.